Skip to main content
Log in

Effectiveness and Limitation of Gamma Knife Radiosurgery for Relapsed Central Nervous System Lymphoma: A Retrospective Analysis in One Institution

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

We describe 6 patients with relapsed central nervous system lymphoma (CNSL) treated with Gamma Knife radiosurgery (GKR). The histologic diagnosis in all 6 patients was diffuse large B-cell lymphoma without human immunodeficiency virus infection. Two patients had intracranial relapse of primary CNSL, and the remaining 4 had CNS relapse of systemic lymphoma. All patients were treated with GKR without severe adverse effects, and all but 1 patient received subsequent chemotherapy shortly after GKR. Four patients showed a complete response, and the remaining 2 patients had a partial response or stable disease. Although the neurologic symptoms disappeared or improved markedly in all patients, all of the diseases recurred or progressed 3 to 13 months after the first GKR. A second GKR was eventually performed in 4 patients. The median overall survival and progression-free survival times after the first GKR were 17 and 11 months, respectively. In our experience, GKR seems to be a useful procedure for the treatment of relapsed CNSL, because it facilitates excellent local control in a short-term treatment period without severe complications, although the efficacy period is not long enough.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Krogh-Jensen M, d’Amore F, Jensen MK, et al. Incidence, clinico-pathological features and outcome of primary central nervous system lymphomas: population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO. Ann Oncol. 1994;5:349–354.

    Article  PubMed  CAS  Google Scholar 

  2. DeAngelis LM. Primary central nervous system lymphoma: a new clinical challenge. Neurology. 1991;41:619–621.

    Article  PubMed  CAS  Google Scholar 

  3. Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol. 2000;18:3144–3150.

    Article  PubMed  CAS  Google Scholar 

  4. DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol. 2002;20:4643–4648.

    Article  PubMed  Google Scholar 

  5. Bollen EL, Brouwer RE, Hamers S, et al. Central nervous system relapse in non-Hodgkin lymphoma: a single-center study of 532 patients. Arch Neurol. 1997;54:854–859.

    Article  PubMed  CAS  Google Scholar 

  6. Hoerni-Simon G, Suchaud JP, Eghbali H, et al. Secondary involvement of the central nervous system in malignant non-Hodgkin’s lymphoma: a study of 30 cases in a series of 498 patients. Oncology. 1987;44:98–101.

    Article  PubMed  CAS  Google Scholar 

  7. Bashir RM, Bierman PJ, Vose JM, et al. Central nervous system involvement in patients with diffuse aggressive non-Hodgkin’s lymphoma. Am J Clin Oncol. 1991;14:478–482.

    Article  PubMed  CAS  Google Scholar 

  8. Recht L, Straus DJ, Cirrincione C, et al. Central nervous system metastases from non-Hodgkin’s lymphoma: treatment and prophylaxis. Am J Med. 1988;84:425–435.

    Article  PubMed  CAS  Google Scholar 

  9. van Besien K, Ha CS, Murphy S, et al. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood. 1998;91:1178–1184.

    PubMed  Google Scholar 

  10. Zinzani PL, Magagnoli M, Frezza G, et al. Isolated central nervous system relapse in aggressive non-Hodgkin’s lymphoma: the Bologna experience. Leuk Lymphoma. 1999;32:571–576.

    Article  PubMed  CAS  Google Scholar 

  11. Hollender A, Kvaloy S, Lote K, Nome O, Holte H. Prognostic factors in 140 adult patients with non-Hodgkin’s lymphoma with systemic central nervous system (CNS) involvement: a single centre analysis. Eur J Cancer. 2000;36:1762–1768.

    Article  PubMed  CAS  Google Scholar 

  12. Bokstein F, Lossos A, Lossos IS, SiegalT. Central nervous system relapse of systemic non-Hodgkin’s lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy. Leuk Lymphoma. 2002;43:587–593.

    Article  PubMed  CAS  Google Scholar 

  13. Jahnke K, Thiel E, Martus P, Schwartz S, KorfelA. Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system. Ann Haematol. 2005;85: 45–50.

    Article  Google Scholar 

  14. Jahnke K,Thiel E, Martus P, et al, on behalf of the German Primary Central Nervous System Lymphoma Study Group (G-PCNSLSG). Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neurooncol. 2006;80:159–165.

    Article  PubMed  Google Scholar 

  15. Kawamura T, Koga S, Okamoto M, Kanno T, Iwamura H. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS). Rad Med. 2001;19:145–149.

    CAS  Google Scholar 

  16. Nicolato A, Gerosa MA, Foroni R, et al. Gamma Knife radiosurgery in AIDS-related primary central nervous system lymphoma. Stereotact Funct Neurosurg. 1995;64(suppl 1):42–55.

    Article  PubMed  Google Scholar 

  17. Dong Y, Pan L, Wang B, et al. Stereotactic radiosurgery in the treatment of primary central nervous system lymphoma. Chin Med J (Engl). 2003;116:1166–1170.

    PubMed  Google Scholar 

  18. Campbell PG, Jawahar A, Fowler MR, Delaune A, Nanda A. Primary central nervous system lymphoma of the brain stem responding favorably to radiosurgery: a case report and literature review. Surg Neurol. 2005;64:400–405.

    Article  PubMed  Google Scholar 

  19. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665–1672.

    Article  PubMed  Google Scholar 

  20. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas: NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244–1253.

    Article  PubMed  CAS  Google Scholar 

  21. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol. 1989;7: 1630–1636.

    Article  PubMed  CAS  Google Scholar 

  22. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989;39:789–796.

    Article  PubMed  CAS  Google Scholar 

  23. Vigliani MC, Duyckaerts C, Hauw JJ, Poisson M, Magdelenat H, Delattre JY. Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: a clinical and pathological study. J Neurooncol. 1999;41:137–149.

    Article  PubMed  CAS  Google Scholar 

  24. Lai R, Abrey LE, Rosenblum MK, DeAngelis LM. Treatment- induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study. Neurology. 2004;62:451–456.

    Article  PubMed  Google Scholar 

  25. Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T, Fukushima T. Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy. J Neurooncol. 2003;63:87–95.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yosuke Matsumoto.

About this article

Cite this article

Matsumoto, Y., Horiike, S., Fujimoto, Y. et al. Effectiveness and Limitation of Gamma Knife Radiosurgery for Relapsed Central Nervous System Lymphoma: A Retrospective Analysis in One Institution. Int J Hematol 85, 333–337 (2007). https://doi.org/10.1532/IJH97.06205

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.06205

Key words

Navigation